Natterman Bronchicum Extra Sterk (Codeine Phosphate Hemihydrate)

Codeine phosphate is a mu‑opioid receptor agonist. By binding to µ‑receptors in the central nervous system, especially in the medullary cough centre, it raises the threshold for cough reflex activation, thereby suppressing cough. It also exerts mild analgesic effects through the same receptor pathway.

The specific dose of Natterman Bronchicum Extra Sterk is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and local regulatory guidelines. Patients should follow the prescriber’s instructions and the product label; dosing should not be altered without medical advice.

Safety data for codeine phosphate during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑opioid antitussives such as dextromethorphan, codeine phosphate provides a stronger central cough‑suppressing effect due to its µ‑opioid receptor activity, but it also carries a higher risk of opioid‑related adverse effects and dependence. Selection depends on the severity of cough, patient risk factors and clinical judgment.

Natterman Bronchicum Extra Sterk should be stored below 25 °C in a dry place, protected from moisture and direct sunlight. Keep the product in its original packaging until use, and ensure that it is out of reach of children. Do not store in bathrooms or near heat sources.

The product is intended for oral administration. Patients should swallow the tablet whole with a glass of water, unless the prescribing information advises otherwise. It is usually taken as needed for cough relief, but the exact frequency and timing should follow the prescriber’s directions to avoid excessive dosing.

The most serious risks associated with codeine phosphate include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions such as anaphylaxis, and the potential for dependence or abuse. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or uncontrolled cravings.

Natterman Bronchicum Extra Sterk should be avoided in individuals with known hypersensitivity to codeine or any component of the formulation, in patients with severe respiratory insufficiency, in those with acute or severe asthma, and in persons with a history of opioid dependence or abuse. Caution is also advised for children, the elderly, and patients with significant hepatic or renal impairment.